Nor Christian Torp1, Kitty Dahl2, Gudmundur Skarphedinsson2, Per Hove Thomsen3, Robert Valderhaug4, Bernhard Weidle4, Karin Holmgren Melin5, Katja Hybel3, Judit Becker Nissen3, Fabian Lenhard6, Tore Wentzel-Larsen2, Martin E Franklin7, Tord Ivarsson2. 1. Centre for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo, Norway; Department of Child and Adolescent Psychiatry, Division of Mental Health and Addiction, Vestre Viken Hospital, Drammen, Norway. Electronic address: nor.christian.torp@r-bup.no. 2. Centre for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo, Norway. 3. Aarhus University Hospital, Regional Center for Child and Adolescent Psychiatry, Risskov, Aarhus, Denmark. 4. Regional Centre for Child and Youth Mental Health and Child Welfare, Faculty of Medicine, NTNU, Trondheim, Norway. 5. Department of Child and Adolescent Psychiatry, Queen Silva Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden. 6. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. 7. Department of Psychiatry, University of Pennsylvania School of Medicine, USA.
Abstract
OBJECTIVE: The purpose of this study was to examine the acute effectiveness of manualized exposure-based CBT with a family-based treatment, as an initial treatment for pediatric OCD delivered in regular community child and adolescents outpatient clinics. The report summarizes outcome of the first treatment step in the NordLOTS, which was conducted in Denmark, Sweden and Norway. METHOD: 269 participants, age 7-17, with OCD, received treatment for 14 weekly sessions. Treatment response was defined as CY-BOCS score of ≤15 at post treatment. RESULTS: 241 participants (89.6%) completed all 14 weeks of treatment. Treatment response among the completers was 72.6% (95% CI 66.7%-77.9%). Mixed effects model revealed a statistically significant effect of time F(1,479) = 130.434. Mean symptom reduction on the CY-BOCS was 52.9% (SD = 30.9). The estimated within-group effect size between baseline and post treatment was 1.58 (95% CI: 1.37-1.80). CONCLUSION: This study found that manualized CBT can be applied effectively in community mental health clinics. These findings underscore the feasibility of implementing exposure-based CBT for pediatric OCD in a regular child and adolescent mental health setting. CLINICAL TRIALS REGISTRATION INFORMATION: This study was registered in Current Controlled Trials; Nordic Long-term Obsessive-compulsive disorder (OCD) Treatment Study (www.controlled-trials.com ISRCTN66385119).
OBJECTIVE: The purpose of this study was to examine the acute effectiveness of manualized exposure-based CBT with a family-based treatment, as an initial treatment for pediatric OCD delivered in regular community child and adolescents outpatient clinics. The report summarizes outcome of the first treatment step in the NordLOTS, which was conducted in Denmark, Sweden and Norway. METHOD: 269 participants, age 7-17, with OCD, received treatment for 14 weekly sessions. Treatment response was defined as CY-BOCS score of ≤15 at post treatment. RESULTS: 241 participants (89.6%) completed all 14 weeks of treatment. Treatment response among the completers was 72.6% (95% CI 66.7%-77.9%). Mixed effects model revealed a statistically significant effect of time F(1,479) = 130.434. Mean symptom reduction on the CY-BOCS was 52.9% (SD = 30.9). The estimated within-group effect size between baseline and post treatment was 1.58 (95% CI: 1.37-1.80). CONCLUSION: This study found that manualized CBT can be applied effectively in community mental health clinics. These findings underscore the feasibility of implementing exposure-based CBT for pediatric OCD in a regular child and adolescent mental health setting. CLINICAL TRIALS REGISTRATION INFORMATION: This study was registered in Current Controlled Trials; Nordic Long-term Obsessive-compulsive disorder (OCD) Treatment Study (www.controlled-trials.com ISRCTN66385119).
Authors: Robert R Selles; Davið R M A Højgaard; Tord Ivarsson; Per Hove Thomsen; Nicole Michelle McBride; Eric A Storch; Daniel Geller; Sabine Wilhelm; Lara J Farrell; Allison M Waters; Sharna Mathieu; S Evelyn Stewart Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-06-20 Impact factor: 8.829
Authors: Anna Villadsen; Mette V Thorgaard; Katja A Hybel; Jens Søndergaard Jensen; Per H Thomsen; Charlotte U Rask Journal: Eur Child Adolesc Psychiatry Date: 2016-06-29 Impact factor: 4.785
Authors: Trine Wigh Arildskov; David R M A Højgaard; Gudmundur Skarphedinsson; Per Hove Thomsen; Tord Ivarsson; Bernhard Weidle; Karin Holmgren Melin; Katja A Hybel Journal: Eur Child Adolesc Psychiatry Date: 2015-10-30 Impact factor: 4.785
Authors: Tara S Peris; Michelle S Rozenman; Catherine A Sugar; James T McCracken; John Piacentini Journal: J Am Acad Child Adolesc Psychiatry Date: 2017-10-14 Impact factor: 8.829
Authors: Michelle Rozenman; John Piacentini; Joseph O'Neill; R Lindsey Bergman; Susanna Chang; Tara S Peris Journal: Psychiatry Res Date: 2019-04-19 Impact factor: 3.222
Authors: Gudmundur Skarphedinsson; Alessandro S De Nadai; Eric A Storch; Adam B Lewin; Tord Ivarsson Journal: Eur Child Adolesc Psychiatry Date: 2016-05-21 Impact factor: 4.785